Dry Powder Inhaler Market: Overview
Dry powder inhaler is a medical device that is used for the effective delivery of medication to the lungs. The medication comes in the form of dry powder. The patients who suffer from various respiratory diseases make use of the dry powder inhalers as they are portable and are easy to carry.
Dry Powder Inhaler Market: Facts
The market player Inspiro Medical has developed the product Inspiromatic™ which is an advanced version of the dry powder inhalers. The device has an active dry powder fluidization mechanism which works in the low inhalation flow rates.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Dry Powder Inhaler Market: Segmentation
The global market for the dry powder inhaler is fragmented into its product type, application, and end-user industry. Based on the product type, the global market is segregated into multi-dose dry powder inhaler and single dose dry powder inhaler. Based on the application, the market is categorized into COPD, cardiovascular diseases, asthma, diabetes, cystic fibrosis, and others. Based on the end-user industry, the market is divided into home & personal care and clinics & hospitals.
Dry Powder Inhaler Market: Growth Factors
The patients that suffer from different types of respiratory diseases have a major concern regarding taking of accurate dosage of medicines. The factors that are contributing to the growth of the market are the rise in the number of the cases being registered of respiratory disease and the rise in the aging population increases the demand for the dry powder inhalers. The market players are trying to develop various innovations in the devices that are used for the inhalation purposes thus propelling the growth of the market. The opportunities for the market are increasing as the manufacturers are trying to use new methods such as computational fluid dynamics for the development of the new generation products. The factors that are limiting the growth of the market are these devices are not resistant to moisture thus if the medicine comes in contact with moisture it loses its properties and the availability of the other competitive products in the market such as electric pumps and nebulizers.
Dry Powder Inhaler Market: Regional Analysis
The market for the dry powder inhaler is dominated by the North American region. The major factor that contributes to the market growth is the early adoption of the advanced medical technologies in this region. Europe is following the North American region and is expected to grow rapidly in the coming years owing to the presence of the major pharmaceutical companies in this region. There are huge investments made by the market players for the development of the healthcare sector in this region. In Asia Pacific region, the market will grow at a good speed owing to the increasing disposable income and the developing economy in the region. In Asia Pacific region, there is a significant growth in the geriatric population which is increasing the demand for the dry powder inhalers.
Dry Powder Inhaler Market: Competitive Players
The key market players that are involved in the dry powder inhaler market include Cipla Inc., GlaxoSmithKline Plc., Teicos Pharma Ltd., Presspart Manufacturing Ltd., Beximco Pharma Ltd., Catalent, Inc., Hovione FarmaCiencia SA., AstraZeneca Plc., Bespak Europe Ltd., Luckys Pharma, and SRS Pharmaceuticals Pvt. Ltd.
Dry Powder Inhaler Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets